Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series

Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series

Background: Interstitial lung diseases (ILDs) are a heterogeneous group of conditions that can cause fibrosis of the lung interstitium, resulting in respiratory failure and death. Patients with an ILD, particularly idiopathic pulmonary fibrosis (IPF) or connective tissue disease-associated ILDs (CTD...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria Angela Licata, Giorgio Monteleone, Enrico Schiavi, Maria Musso, Paola Mencarini, Annelisa Mastrobattista, Serena Maria Carli, Carlotta Cerva, Giacomo Sgalla, Luca Richeldi, Fabrizio Palmieri, Gina Gualano
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Infectious Disease Reports
Subjects:	interstitial lung diseases (ILDs) idiopathic pulmonary fibrosis (IPF) usual interstitial pneumonia (UIP) tuberculosis (TB) non-tuberculous mycobacterial pulmonary disease (NTM-PD)
Online Access:	https://www.mdpi.com/2036-7449/17/2/28
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons
by: Giacomo Giulianelli, et al.
Published: (2025-05-01)

Clinical Utility of Induced Sputum and Bronchoalveolar Lavage Cultures in Diagnosing Nontuberculous Mycobacterial Pulmonary Disease
by: Maria Angela Licata, et al.
Published: (2024-12-01)

Differential Diagnosis of Fibrotic Hypersensitivity Pneumonitis with Its Non-Fibrotic Phenotype and Usual Interstitial Pneumonia During High-Resolution Computed Tomography
by: I. E. Tuyrin, et al.
Published: (2023-11-01)

Prediction of Pulmonary Hypertension in Patients with Diffuse Parenchymal Lung Disease using Forced Vital Capacity/ Diffusion Capacity of Lung using Carbon Monoxide Ratio: A Cross-sectional Study
by: Anubhab Moulik, et al.
Published: (2025-03-01)

“POSSIBLE” OR “PROBABLE”. THE NEW APPROACH IN IDIOPATHIC PULMONARY FIBROSIS DIAGNOSIS
by: D. V. Petrov, et al.
Published: (2018-08-01)

IDIOPATHIC PULMONARY FIBROSIS. CORRECTION OF ERRORS
by: A. L. Yudin, et al.
Published: (2018-12-01)

The role of lung cancer in mortality rate in chronic fibrosing idiopathic interstitial pneumonia
by: Beatriz Morales Chacón, et al.
Published: (2025-05-01)

Prognostic significance of acute exacerbations and usual interstitial pneumonia in fibrotic interstitial lung disease
by: Yun Zhang, et al.
Published: (2025-07-01)

The impact of the COVID-19 pandemic on the profile of interstitial lung disease presenting to the pulmonary medicine department of a tertiary care center in western India
by: Unnati Desai, et al.
Published: (2025-03-01)

ITGAV, a specific biomarker associated with the pathogenesis of idiopathic pulmonary fibrosis
by: Zhangyang Bi, et al.
Published: (2025-05-01)

Immunosuppressive Therapy for Usual Interstitial Pneumonia in Autoimmune Rheumatic Diseases: A Review
by: Domenico Sambataro, et al.
Published: (2025-03-01)

A clinical case of idiopathic pulmonary fibrosis against the background of comorbid pathology
by: A. V. Teteneva, et al.
Published: (2021-10-01)

Interstitial lung disease in a female patient with rheumatoid arthritis
by: Yuliya Valeryavna Averkieva, et al.
Published: (2014-03-01)

From Gut to Lung: The Role of Bile Acids in Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)
by: Shi YJ, et al.
Published: (2025-08-01)

Association of peripheral leukocyte telomere length with patients with rheumatoid arthritis with a focus on interstitial lung disease
by: Young Bin Joo, et al.
Published: (2025-07-01)

Integrating Radiomics Signature into Clinical Pathway for Patients with Progressive Pulmonary Fibrosis
by: Giacomo Sica, et al.
Published: (2025-01-01)

Persistent microbial infections and idiopathic pulmonary fibrosis - an insight into non-typeable Haemophilus influenza pathogenesis
by: Anthony Shadid, et al.
Published: (2024-12-01)

Role Of High-Resolution CT Thorax in Interstitial Lung Disease Evaluation
by: Surinder Singh, et al.
Published: (2025-04-01)

Alveolar cell composition in interstitial lung disease and the development of a pulmonary progressive fibrosing phenotype: a retrospective cohort study
by: Iris A. Simons, et al.
Published: (2025-04-01)

Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns
by: Cinzia Rotondo, et al.
Published: (2025-02-01)

Outcomes with venoarterial vs venovenous extracorporeal membrane oxygenation as a bridge to lung transplantation in interstitial lung disease
by: Prasanth Balasubramanian, MD, et al.
Published: (2025-08-01)

Radiological and Clinical Presentation of Interstitial Lung Disease in Patients with Concomitant Psoriasis: A Cross-sectional Study
by: Manoj Meena, et al.
Published: (2025-04-01)

Insights from the European Nontuberculous mycobacterial pulmonary disease PAtient Disease Experience (ENPADE) survey– exploring disease burden and impact
by: Michal Shteinberg, et al.
Published: (2025-02-01)

Vascular volume changes in radiological patterns of usual interstitial pneumonia in patients with type 2 diabetes
by: Jiarong Wang, et al.
Published: (2024-12-01)

Co-ablation of lung malignancies with coexisting usual interstitial pneumonia: a retrospective analysis of safety and efficacy
by: Yu-Feng Wang, et al.
Published: (2025-12-01)

Prevalence and clinical significance of anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis-associated interstitial lung disease
by: Zhe Huang, et al.
Published: (2025-04-01)

Diagnosis, screening, and follow-up of patients with familial interstitial lung disease: Results from an international survey
by: Emil Vilstrup Moen, et al.
Published: (2025-02-01)

Comparison of rituximab vs. cyclophosphamide in rheumatoid arthritis-associated interstitial lung disease and its correlation with spirometry
by: Mohammed Abdullah Saleem, et al.
Published: (2024-12-01)

Chest CT in Pulmonary Fibrosis: A Narrative Review of Imaging Patterns and Their Prognostic Significance
by: Mehrshad Dabbagh, et al.
Published: (2025-06-01)

Lymphoid Interstitial Pneumonia Without Known Cause: Diagnostic Work Up and Differential Considerations
by: Han Xin Lau, et al.
Published: (2025-04-01)

Case report: Pulmonary non-Langerhans cell histiocytosis in a dog with acute interstitial granulomatous pneumonia
by: Kyle L. Granger, et al.
Published: (2025-02-01)

Editorial: Non-tuberculous mycobacteria infections and COVID-19
by: Vishwanath Venketaraman
Published: (2025-02-01)

Fibroblasts in rheumatoid arthritis: novel roles in joint inflammation and beyond
by: Elpida Neofotistou-Themeli, et al.
Published: (2025-01-01)

Quantitative CT Assessment of Pulmonary Fibrosis Severity in Patients with Connective Tissue Disease-associated Interstitial Lung Disease
by: Ke WANG, et al.
Published: (2025-07-01)

Effect of pulmonary rehabilitation program in patients with interstitial lung disease with or without pulmonary hypertension
by: Mona Abd Elsalam Taha El Gazzar, et al.
Published: (2025-05-01)

Imaging in connective tissue disease-associated interstitial lung disease
by: Praveen P G. Rao, et al.
Published: (2021-01-01)

Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease
by: Aparna C Swaminathan, et al.
Published: (2024-10-01)

Review of research on pulmonary cysts in sjögren’s syndrome
by: Cai-Hong Pan, et al.
Published: (2025-07-01)

Development of prevalence and incidence of non-tuberculous mycobacteria in German laboratories from 2016 to 2020
by: Caroline Corbett, et al.
Published: (2023-12-01)

Physician perspectives on pulmonary hypertension in ILD: results of a cases-based survey
by: Ho Cheol Kim, et al.
Published: (2025-05-01)